Skip to main content
PLOS One logoLink to PLOS One
. 2018 Jan 16;13(1):e0191508. doi: 10.1371/journal.pone.0191508

Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition

Andreas Austgulen Westin, Malin Brekke, Espen Molden, Eirik Skogvoll, Olav Spigset
PMCID: PMC5770058  PMID: 29338054

The affiliation for the 1st author is incomplete. Andreas Austgulen Westin is affiliated with #1 and #6.

There is an error in the caption for Fig 1, “Inclusion flow chart.” Please see the complete, correct Fig 1 caption here.

Fig 1. Inclusion flow chart.

Fig 1

Sample identification and inclusion of therapeutic drug monitoring samples of selective serotonin reuptake inhibitors and venlafaxine obtained during pregnancy. a Five analyses were excluded due to the following drug interactions: sertraline + carbamazepine (n = 1), venlafaxine + bupropion (n = 4).

Reference


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES